The nation of Zimbabwe has rejected a major US health deal valued at 367 million US dollars (272 million pounds) spanning five years over the United States' insistence on sensitive information.
The decision was revealed after a official document from December was disclosed, revealing that Head of State Emmerson Mnangagwa deemed the agreement was "lopsided".
A government spokesman later stated that the US was seeking health data for scientific study and commercial gain while refused to guarantee the resulting advantages from any future medical innovations.
"We must now begin the challenging and unfortunate process of ending our support in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont publicly.
Her embassy said the US had provided more than $1.9bn in health funding to Zimbabwe over the last twenty years.
A physicians' group in Zimbabwe has appealed for further talks to secure a agreement agreeable to both sides so the country's vital HIV programme can be sustained.
Wider Context
This rejection follows a comparable situation in neighbouring Kenya, where a high court blocked a related deal with the US following legal challenges were filed about the security of citizens' health data.
After returning to office recently, US President Donald Trump has slashed overseas assistance and closed the US Agency for International Development (USAID).
The agency had administered assistance for the American government, but Trump stated its expenditure was "wasteful" and his government was pursuing government-to-government agreements to enhance transparency and responsibility.
According to reports, Sixteen nations in Africa have so far agreed to these new agreements, constituting over $18.3bn of fresh investment.
Details of the Declined Agreement
The funds for Zimbabwe would have gone towards "combating HIV/Aids, TB, malaria, maternal and child health, and disease outbreak preparedness.
"It is our view this partnership might have yielded immense advantages for Zimbabwean communities, especially the 1.2 million currently on HIV treatment via American-funded initiatives," Tremont commented.
However, government spokesperson Nick Mangwana said the arrangement was "unfair".
"The proposal required Zimbabwe to surrender its genetic material and health information indefinitely, with no corresponding guarantee of access to any medical innovations – like new medicines or tests – that might be developed from that shared data," his statement read.
"In essence, our country would provide the basic resources for medical research with no certainty that the end products would be accessible to our citizens should a future health crisis emerge."
Sovereignty and Global Health
Mangwana further pointed out that the US's withdrawal from the World Health Organization (WHO) and its pursuit of one-on-one health agreements were undermining systems previously set up via the international health agency.
Mangwana gave as an example its Pathogen Access and Benefit Sharing scheme created to manage future pandemics.
"This mechanism is designed to guarantee that when a country contributes its information, the benefits – including medicines and cures – are distributed fairly, not commercialised exclusively by those with the capability to create them."
The government's concerns regarding the US deal "are not meant as hostility towards the US," Mangwana stressed.
"We are open to ongoing dialogue with our US partners on how subsequent collaboration might be structured in a manner that respects the sovereignty and dignity of each country."
Medical Community Response
A leading public health body expressed it understood the official position, but recommended that negotiations must proceed given that a large portion of the country's Aids initiatives relied on international support.
"Where specific concerns arise, such as those relating to information security or implementation frameworks, these can often be resolved via technical clarification and negotiated safeguards," it said.
This impasse highlights the complex debate between receiving vital international aid and safeguarding national sovereignty in an ever more data-driven world.